SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes
Patients with type 2 diabetes treated with SGLT2 inhibitors vs other common diabetes drugs show up to a 31% reduced risk of kidney stone development.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Kidney Stones | SGLT2 Inhibitors | Urology & Nephrology